Ivermectin may help control malaria

Embargoed until: Publicly released: 2025-07-24 07:00

International

Photo by National Institute of Allergy and Infectious Diseases on Unsplash

A seasonal mass administration of ivermectin once a month could help communities at risk of malaria to reduce their risk, according to a trial conducted in Kenya. Groups of household areas received either ivermectin or the worm treatment albendazole as a comparison, once a month for three consecutive months at the beginning of the 'short rains' season. The researchers found that kids living in areas with high coverage and use of bed nets and ivermectin use had a 26% lower incidence of malaria than those who used albendazole.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Massachusetts Medical Society, Web page Please link to the article in online versions of your report (the URL will go live after the embargo ends).

Editorial / Opinion Massachusetts Medical Society, Web page Please link to the article in online versions of your report (the URL will go live after the embargo ends).

Journal/
conference: New England Journal of Medicine

Research:Paper

Organisation/s: Universidad de Navarra, Spain, Barcelona Institute for Global Health, Spain

Funder: Funded by Unitaid; BOHEMIA ClinicalTrials.gov number, NCT04966702; Pan African Clinical Trial Registry number, PACTR202106695877303

Media Contact/s

Contact details are only visible to registered journalists.